|
Market Closed -
Börse Stuttgart
01:25:37 10/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 35.60 EUR | -0.56% |
|
+0.56% | -12.75% |
| 07/10 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| 07/10 | European Equities Traded in US as ADRs Fall in Wednesday Trading | MT |
| Market Cap | 8.57TCr 9.59TCr 7.97TCr 7.25TCr 14TCr 9,28500Cr 14TCr 96TCr 38TCr 4,73400Cr 36TCr 35TCr 15,19200Cr | P/E 2026 * |
11.4x | P/E 2027 * | 9.92x |
|---|---|---|---|---|---|
| Enterprise Value | 9.7TCr 11TCr 9.03TCr 8.21TCr 16TCr 10,51400Cr 16TCr 1,08600Cr 43TCr 5,36000Cr 41TCr 40TCr 17,20100Cr | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.86x |
| Free-Float |
88.34% | Yield 2026 * |
5.95% | Yield 2027 * | 6.3% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNY | Delayed | |
CBOE
| SNY | Real-time | |
|
London S.E.
| 0A2V | Delayed | |
|
Mexican S.E.
| SNY N | End-of-day quote | |
|
Tradegate
| SNW2 | Real-time | |
|
Boerse Muenchen
| SNW2 | Real-time | |
|
Deutsche Boerse AG
| SNW2 | Delayed | |
|
Börse Stuttgart
| SNW2 | Delayed |
Last Transcript: Sanofi
| 1 week | +0.56% | ||
| Current month | -2.20% | ||
| 1 month | -3.26% | ||
| 3 months | -7.29% | ||
| 6 months | -11.44% | ||
| Current year | -12.75% |
| 1 week | 34.8 |  | 35.8 |
| 1 month | 34.6 | | 37.6 |
| 3 years | 34.6 | | 55 |
| 5 years | 34.6 | | 55 |
| 10 years | 30.6 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | +0.56% | -15.64% | -29.50% | 9.59TCr | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,05100Cr | |
| +1.93% | +2.11% | +36.82% | +64.90% | 63TCr | |
| +1.49% | +5.19% | +19.84% | +85.41% | 49TCr | |
| +2.26% | +0.90% | +66.40% | +39.33% | 36TCr | |
| +1.45% | +3.50% | +21.87% | +42.64% | 34TCr | |
| +1.17% | +2.37% | +11.71% | +35.14% | 27TCr | |
| +0.89% | +1.08% | -7.28% | +10.52% | 25TCr | |
| +1.82% | +2.94% | +40.43% | +52.78% | 22TCr | |
| +2.77% | +4.44% | +29.49% | +101.40% | 19TCr | |
| Average | +1.50% | +2.53% | +24.15% | +50.89% | 42.26TCr | |
| Weighted average by Cap. | +1.20% | +2.44% | +30.41% | +67.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.73TCr 5.3TCr 4.4TCr 4.01TCr 7.56TCr 5,13100Cr 7.6TCr 53TCr 21TCr 2,61600Cr 20TCr 19TCr 8,39400Cr | 5.05TCr 5.65TCr 4.69TCr 4.27TCr 8.06TCr 5,46900Cr 8.1TCr 57TCr 22TCr 2,78800Cr 21TCr 21TCr 8,94700Cr |
| Net income | 745.84Cr 835.11Cr 693.82Cr 631.09Cr 1.19TCr 81TCr 1.2TCr 8.35TCr 3.27TCr 41TCr 3.14TCr 3.07TCr 1,32200Cr | 888.83Cr 995.22Cr 826.84Cr 752.08Cr 1.42TCr 96TCr 1.43TCr 9.95TCr 3.9TCr 49TCr 3.74TCr 3.66TCr 1,57600Cr |
| Net Debt | 1.13TCr 1.27TCr 1.05TCr 959.17Cr 1.81TCr 1,22800Cr 1.82TCr 13TCr 4.97TCr 63TCr 4.77TCr 4.66TCr 2,01000Cr | 800.37Cr 896.17Cr 744.54Cr 677.22Cr 1.28TCr 87TCr 1.28TCr 8.96TCr 3.51TCr 44TCr 3.37TCr 3.29TCr 1,41900Cr |
| Date | Price | Change |
|---|---|---|
| 09/26/09 | €35.60 | -0.56% |
| 08/26/08 | €35.80 | 0.00% |
| 07/26/07 | €35.80 | +2.29% |
| 06/26/06 | €35.00 | -0.57% |
| 05/26/05 | €35.20 | -0.56% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
